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Abstract 
Background and Objective: Lipopolysaccharide (LPS)-mediated signaling in host cells 
involves Toll-like receptor 4 (TLR4), accessory molecules including LPS-binding protein 
(LBP), CD14 and MD-2. However, expression of these innate defense molecules in various 
compartments of human periodontium remained unclear. This study aims to investigate the 
expression profile of TLR4 in human gingiva.  
 
Material and Methods: Human gingival biopsies were collected from healthy gingival or 
chronic periodontitis tissue. Primary gingival keratinocytes and fibroblasts were cultured. 
Immunohistochemical analysis for TLR4 was performed. Transcripts of TLR4, MD-2, CD14 
and LBP, and their protein products were examined using reverse transcription PCR, 
immunoprecipitation and immunoblotting. The interactions between these molecules in 
keratinocytes and fibroblasts were investigated by co-immunoprecipitation.  
 
Results: TLR4 immunoreactivity was found in healthy gingival epithelium and periodontitis 
tissue, which appeared lower in junctional epithelium (P≤0.01). Fibroblasts and inflammatory 
cells stained more intensively for TLR4 in diseased periodontal tissues (P<0.001). Three 
TLR4 splicing variants, two MD-2 splicing variants, and one CD14 mRNA were expressed 
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by gingival keratinocytes and fibroblasts. Protein expression of TLR4, CD14 and MD-2 were 
detected in keratinocytes and fibroblasts in vitro. TLR4 protein from gingival keratinocytes 
and fibroblasts could be co-immunoprecipitated with CD14 or MD-2, suggesting the 
association of the related molecules in vivo. LBP transcript was detected in gingival biopsies 
but not in primary cultures of gingival keratinocytes or fibroblasts. 
 
Conclusion: TLR4, CD14 and MD-2, but not LBP, were expressed in human gingival 
keratinocytes and fibroblasts. TLR4 expression level in junctional epithelium appeared to be 
the lowest within periodontal epithelial barrier. 
 
Key words: Antigens, CD14; chronic periodontitis; fibroblasts; keratinocytes; lymphocyte 
antigen 96; Toll-like receptor 4 
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Lipopolysaccharides (LPS) as cell wall components of gram-negative periodontopathogenic 
bacteria, are conserved structural motifs known as pathogen associated molecular pattern 
(PAMP). They are important factors for mediating the host immune response that initiates 
inflammatory changes during periodontitis. The pathological effects of LPS is mainly mediated 
through molecules expressed on host cells such as Toll-like receptor 4 (TLR4) alongside 
co-receptor cluster of differentiation 14 (CD14), accessory molecule lymphocyte antigen 96 
(MD-2) in the presence of a liver derived soluble acute-phase protein or the LPS-binding 
protein (LBP). The recognition of LPS by the host cells is believed to be first initiated by LBP 
which specifically binds LPS. The LPS bound LBP interacts with membrane bound CD14 on 
the target cell to form a complex, which the latter was transferred to the MD-2 accessory 
molecule forming a trimeric LPS/MD-2/TLR4 complex. The MD-2 accessory molecule is a 
secretary glycoprotein associated with the ectodomain of TLR4. The LPS receptor-complex 
initiates the recruitment of adapter proteins to the intracellular domains of TLR4, which in turn 
triggers the signaling cascade leading to the nuclear translocation of transcription factors and 
the production of inflammatory cytokines (1). In this system, TLR4 and MD-2 are essential for 
the LPS recognition and function. Previous report demonstrated that Aggregatibacter 
actinomycetemcomitans, Fusobacterium nucleatum, Porphyromonas gingivalis, Prevotella 
intermedia, Prevotella nigrescens, Tannerella forsythensis and Veillonella parvula stimulated 
human embryonic kidney cells through CD14-TLR2, but only A. actinomycetemcomitans and 
V. parvula stimulated the same cells through CD14-TLR4 (2). 
Many studies addressed the expression of LBP, TLR4, CD14 and MD-2 in human 
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gingival tissues, but these findings appeared inconsistent (3-10). While some studies reported 
TLR4 in immune cells of gingival connective tissues (8, 10), others presented with 
immunohistochemical evidence that TLR4 was expressed in human gingival epithelium (3, 7, 
9), especially in the basal cell layer (9); and the expression was enhanced in periodontitis (3, 7, 
9, 10). These studies, however, did not describe any distinctive TLR4 expression profiles of 
junctional epithelium, oral sulcular epithelium or oral epithelium. On the other hand, both 
human TLR4 (11) and MD-2 (12, 13) genes were reported to encode several alternatively 
splicing transcript variants, however their corresponding expression from residential cells 
isolated from gingival tissue has not yet been reported. In the present study, we defined 
different in vivo expression profiles of TLR4 in healthy and periodontitis-involved human 
gingiva followed by examination of the transcript variants and protein products of TLR4, 
CD14 and MD-2 in cultured periodontitis-free primary human gingival epithelial cells and 
fibroblasts.  
 The hypothesis of this study is that TLR4 as one pattern recognition receptor against 
LPS is expressed and detectable as innate defense element in all compartments of the human 
periodontium. 
 
Material and methods 
Periodontal biopsies 
The study was approved by the Institutional Review Board of The University of Hong 
Kong/Hospital Authority Hong Kong West Cluster. The gingival tissue sampling procedure 
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has been reported in our previous study (14, 15). Non-smoking Chinese patients between 35 
and 60 years old, who attended Prince Philip Dental Hospital, the University of Hong Kong, 
were recruited to this study between September 2006 and January 2009. Participants had to be 
systemically healthy, did not have prior periodontal treatment, and had not received 
antibiotics or anti-inflammatory drugs in the previous 6 months. The purpose of the study and 
the procedures to be involved were explained to the participants and informed consent was 
obtained. 
The inclusion criteria for the periodontitis group were as follows: 1) at least two teeth 
per quadrant showed untreated chronic periodontitis with probing pocket depth (PPD) > 6 
mm and probing attachment level (PAL) > 5.0 mm; 2) radiographic evidence of alveolar bone 
loss; and 3) at least one periodontally involved tooth was scheduled for extraction or 
periodontal surgery. The inclusion criteria for the control group were as follows: 1) no sites 
with PPD ≥ 3 mm or PAL ≥ 1 mm; 2) no radiographic evidence of periodontal bone loss > 
10% or any furcation involvement in multi-rooted teeth; 3) full-mouth bleeding on probing 
score ≤ 30%, and (4) a tooth scheduled for crown-lengthening surgery or extraction for 
orthodontic or prosthodontic reasons. To obtain gingival biopsies with intact junctional or 
pocket epithelium, gingival biopsies were collected through internal beveled incision extended 
below marginal periodontal bone into periodontal space as deep as possible, as described in 
our previous report (15).  
 Forty-four gingival biopsies were obtained from patients with advanced chronic 
periodontitis (46.3 ± 9.1 years; 23 females). Immunohistochemistry, immunoprecipitation and 
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immunoblotting were performed on 38, 3 and 3 samples, respectively. Thirty-four control 
samples were obtained from healthy subjects (42.2 ± 5.8 years; 19 females). 
Immunohistochemistry, reverse transcription polymerase chain reaction (RT-PCR), 
immunoprecipitation and immunoblotting were performed on 10, 5, 3 and 3 samples, 
respectively. Cell explants (isolation of both human gingival fibroblasts and keratinocytes) 
were prepared from thirteen control samples. Out of them, RT-PCR, immunoprecipitation and 
immunoblotting were performed on cells from 9, 7 and 10 samples, respectively. 
 
Immunohistochemistry 
Samples were fixed in 10% neutral buffered formalin solution for 24 hours before being 
dehydrated and embedded in paraffin blocks. Sections (4 µm thickness) were cut and mounted 
on silicon-coated slides. After the sections were dewaxed and rehydrated, they were treated 
with 3% hydrogen peroxide and heated in a buffer (0.05% Tween 20, 1mM EDTA, 10mM 
Tris HCl, pH 9.0) at 98°C. After blocking in 2.5% horse serum for 20 minutes, sections were 
incubated with primary antibodies against TLR4 (Rabbit anti-human polyclonal IgG, 1:100, 
sc-10741, Santa Cruz Biotechnology Inc., Santa Cruz, CA.) in 1% bovine albumin at 4°C 
overnight, then stained (ImmPRESS
TM
 Universal Reagent, MP-7500, Vector Laboratories, 
Burlingame, CA) and visualized using a diaminobenzidine (DAB) solution. Sections incubated 
with control normal rabbit IgG (1:100) instead of the primary antibodies were also processed at 
the same time, which were all stained uniformly negative. 
Stained sections were analyzed with a digital imaging system (Leica DC 300 Ver 2.0, 
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Leica, Wetzlar, Germany) and Leica Qwin Standard V 2.6 software (Leica, Wetzlar, 
Germany). For biopsies of healthy group (n=10), gingival epithelium was divided into three 
compartments: junctional epithelium (H-JE), oral sulcular epithelium (H-OSE), and oral 
epithelium (H-OE). Similarly, gingival epithelium of periodontitis group (n=38) was also 
divided into two compartments: pocket epithelium (P-PE) and oral epithelium (P-OE), 
according to their spatial position relative to the free gingival margin. The TLR4 expression in 
different epithelium compartments was evaluated and quantitatively analyzed as the proportion 
of positively stained area over the total area of the defined epithelium compartment and 
presented as area (%) (supplementary Fig. S1). The proportion of subepithelial cells which 
were TLR4-immunoreactive was calculated and presented as count (%) according to a 
protocol described in a previous study (14).  
 
Cell culture 
To obtain pure primary human gingival keratinocytes without contamination from fibroblasts, 
the healthy gingival tissue (HGT) biopsies (n=13) were washed in ice-cooled 
phosphate-buffered saline (PBS) and incubated in 2 U/ml dispase (Cat. No. 17105, GIBCO
TM
 
Invitrogen, Carlsbad, CA) diluted in serum-free Dulbecco's Modified Eagle Medium, (DMEM, 
Cat. 12800-017, GIBCO
TM
 Invitrogen, Carlsbad, CA) at 4°C overnight. The epithelium was 
then mechanically separated from the subepithelial layer as an intact sheet using forceps. The 
epithelium sheet was minced and seeded in a 6-cm diameter culture dish and covered with a 
sterile 22 × 22 mm glass coverslip. The tissue blocks were initially cultured in Oral 
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Keratinocyte Medium (OKM, Cat. 2611, ScienCell
TM
 Research Laboratories, Carlsbad, CA) 
supplemented with 10% fetal bovine serum (FBS, Cat. 10437-036, GIBCO
TM
 Invitrogen, 
Carlsbad, CA). When cells started to grow out of the tissue blocks, FBS was immediately 
removed from the culture medium and the cells and tissue blocks were maintained in OKM. 
Cells at 80% confluence were passaged into a 10-cm diameter culture dish. The cultures were 
then purged of any fibroblast contamination by treating with 0.25% Trypsin in PBS for 3 
minutes. The detached cells were re-seeded in a 6-well culture plate. The purification 
procedure was repeated every other day until no more spindle-shaped cells were found to grow 
in the 6-well culture plate for two successive treatments. Human primary gingival fibroblasts 
were cultured from the de-epithelialized gingival tissues, which were minced and seeded in 
DMEM containing 10% FBS. Both human gingival keratinocytes (HGK) and fibroblasts (HGF) 
from the third passage were used in the following experiments. 
 
Reverse transcription Polymerase Chain Reaction 
Total RNA was extracted from cultured cells (n=9 independent cell explants) and 
periodonotitis-free gingival biopsies (n=5) (RNeasy
®
 Mini Kit, Qiagen, Valencia, CA.). 
First-strand complementary DNA (cDNA) was then synthesized (Superscript First Chain 
Synthesis Kit, Invitrogen, Carlsbad, CA). To amplify the target cDNAs using polymerase 
chain reaction (PCR), oligonucleotide primer pairs were designed with PerlPrimer v1.1.17 
(http://perlprimer.sourceforge.net). The RefSeq names of the Target transcripts, their accession 
numbers in GenBank and the sequences of the oligonucleotide primer pairs were listed below: 
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LBP (NM_004139; Forward: 5'-TCT AAT ATC CGA CTG ACC AC-3', Reverse: 5’-CAG 
CTC TGC ATT GAA TAG TC-3’), CD14 (NM_000591; Forward: 5'-ACT TAT CGA CCA 
TGG AGC G-3', Reverse: 5'-AAG CTG GAA AGT GCA AGT C-3'), MD-2 (NM_015364 for 
MD-2.1; NM_001195797 for MD-2.2; Forward: 5'-CTC AGA AGC AGT ATT GGG T-3', 
Reverse: 5'-AAT TAG GTT GGT GTA GGA TGA C-3'), TLR4 (NM_138554 for TLR4.1; 
NM_003266 for TLR4.3; NM_138557 for TLR4.4; Forward: 5'- GTC AGA CGG TGA TAG 
CGA G-3', Reverse: 5'-GAT GTC CAA TGG GGA AGT T-3'), and GAPDH (NM_002046; 
Forward: 5'-CAA CTT TGG TAT CGT GGA AGG A-3', Reverse: 5'-AAG GTG GAG GAG 
TGG GTG TCG-3'). The cycling conditions were 95°C for 30 seconds, 58°C for 30 seconds 
and 72°C for 45 seconds for 37 cycles. All amplicons were gel purified and sequenced to 
confirm their identity.  
 
Immunoprecipitation and co-immunoprecipitation 
Cells (n=1.0×10
7
 from seven culture explants) and gingival biopsies (n=3 each for 
periodontitis and healthy tissue) were lysed with lysis buffer (1% Triton-X100, 150 mM NaCl, 
20 mM Tris HCl, pH 7.4, and 2 µL/mL protease inhibitor, P8340, Sigma-Aldrich, St. Louis, 
MO), and homogenized on ice. After centrifugation at 12,000× g for 20 minutes at 4°C, the 
supernatant was collected and protein concentrations determined (BCA kit, Pierce 
Biotechnology, Hercules, CA). For immunoprecipitation and co-immunoprecipitation, 500 µg 
of total cellular protein, or 800 µg of total tissue protein or 500 µg BSA in 500 µL protein 
extraction buffer (negative control) were used.  
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As a positive control, human peripheral blood mononuclear cells (PBMC) were isolated 
using Ficoll-Paque
TM
 Premium (Cat. No. 17-5442-02, GE Healthcare Bio-Sciences AB, 
Uppsala, Sweden). Briefly, fresh blood collected from a volunteer was immediately 
supplemented with EDTA to a final concentration of 1.5 mg/mL, and then diluted with equal 
volume of PBS. Four milliliters of the diluted blood sample were carefully layered on 3 mL of 
Ficoll-Paque
TM
 Premium solution in a centrifuge tube. After centrifugation at 400× g for 30 
minutes at 18°C, the PBMC layer between the upper plasma/platelets and the lower 
Ficoll-Paque
TM
 Premium layers was collected and suspended in 6 mL of PBS. After 3 cycles of 
washing and centrifugation in PBS, the PBMC was pelleted and lysed according to the 
aforementioned protocol. Four hundred micrograms of the crude PBMC lysate were used in 
immunoprecipitation and co-immunoprecipitation as positive controls. 
All protein specimens were pre-cleared by addition of 1.0 µg of an appropriate control 
IgG (mouse, rabbit or goat) corresponding to the host species of the primary antibody, 
together with 20 µL of re-suspended Protein A/G PLUS-Agarose beads (sc-2003, Santa Cruz 
Biotechnology Inc., Santa Cruz, CA). After incubation at 4°C for 30 minutes, samples were 
centrifuged at 2,500× g for 2 minutes. The supernatant was collected and 1 µg of antibody 
against either CD14 (sc-1182, Santa Cruz Biotechnology Inc., Santa Cruz, CA) or MD-2 
(sc-20668, Santa Cruz Biotechnology Inc., Santa Cruz, CA) or TLR4 (goat anti-human 
polyclonal antibody, ab53629, ABcam, Cambridge, MA) was added together with 20 µL of 
resuspended Protein A/G PLUS-Agarose beads. The samples were incubated at 4°C overnight. 
After three washes, immunoprecipitates were eluted in 1× electrophoresis sample buffer and 
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run on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), then 
analyzed by immunoblotting.  
 
SDS-PAGE and immunoblotting 
For SDS-PAGE, CD14 [500 µg of concentrated (Centrifugal Filter Devices YM-50, Millipore, 
Bedford, MA) total protein], MD-2 (20 µg of total protein) and TLR4 (protein 
immunoprecipitates) samples were separated by 12% (for CD14 and MD-2) or 7.5% (for 
TLR4) SDS-PAGE before being transferred onto polyvinylidene difluoride membranes. After 
blocking in a buffer (0.05% Tween 20, 5% skimmed milk, 150 mM NaCl, 50 mM Tris HCl, 
pH 7.2), the membranes were incubated overnight with antibodies against CD14 (1:1000) or 
MD-2 (1:500, sc-20668, Santa Cruz Biotechnology Inc., Santa Cruz, CA) or TLR4 (1:1000, 
Cat. MAB1478, R&D, Minneapolis, MN). The blots were visualized using a detection kit 
(WesternBreeze
®
 Chromogenic Immunodetection Kit, Invitrogen, Carlsbad, CA). 
 
Statistical analyses 
Data were analyzed using a statistical package (IBM SPSS 20, Armonk, New York, USA). As 
the normality (checked by Kolmogorow–Smirnoff test) of the data appeared to be valid, 
one-way ANOVA was used to examine the difference between six groups on area (%) of 
TLR4 expression. Post hoc multiple comparisons were performed using Bonferroni tests. For 
the proportion of subepithelial cells, t-test was used to examine differences between the 
control and test groups. The alpha level was set at 0.05. 
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Results 
Localization of TLR4 protein in human gingiva 
In both healthy (Fig. 1) and periodontitis-involved (Fig. 2) periodontal soft tissue, 
TLR4-immunoreactivity could be readily observable in oral epithelium (Fig. 1b, Fig. 2b & 2d), 
oral sulcular epithelium (Fig. 1b, 1c & 1e), pocket epithelium (Fig. 2a, 2e & 2g), while it 
appeared lesser expressed in junctional epithelium (Fig. 1d). The TLR4-immunoreactivity 
appeared to be isolated to the cell membrane (Fig. 1e & Fig. 2d). Statistical analysis 
demonstrated difference in the mean area (%) of TLR4 expression among H-JE, H-OE, 
H-OSE, P-OE and P-PE epithelial compartments (Fig. 3) while post hoc multiple 
comparisons confirmed that TLR4 area (%) were similar among H-OE (34.5 ± 8.2%), H-OSE 
(30.3 ± 8.8%) and P-OE (31.5 ± 8.7%), but were significantly higher than H-JE (16.2 ± 7.6%) 
(P≤0.01, Bonferroni multiple comparisons; Fig. 3). The TLR4 area (%) expression in P-PE 
(25.2 ± 12.5%) did not appear to be statistically different than that of any other epithelial 
compartment in health or disease (Fig. 3). 
In the subepithelial regions, fibroblast-like cells in healthy gingiva were mostly 
unstained for TLR4 (Fig. 1c & 1d), whereas many fibroblast-like cells in periodontitis tissue 
were heavily stained for TLR4, particularly those proximal to the inflammatory infiltration 
(Fig. 2f & 2i).  
In healthy gingiva, leukocyte-like cells were sparsely scattered in oral sulcular 
Page 14 of 37
Journal of Periodontal Research
Journal of Periodontal Research - manuscript proof
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Manuscript proof
 
15 
 
epithelium, junctional epithelium, and the subepithelial regions (Fig. 1c & 1d). These cells 
were mostly negative for TLR4, except those with dendritic morphology. In periodontitis 
tissue, epithelium-infiltrating leukocyte-like cells were largely negative for TLR4, but those 
accumulating in the subepithelial connective tissue were intensely stained (Fig. 2g & 2i). 
Some TLR4-positive leukocyte-like cells appeared to accumulate around a mass of 
TLR4-negative inflammatory cells (Fig. 2h & 2k). The TLR4-immunoreactivity in endothelial 
cells was very weak or absent (Fig. 1 & 2).  
The proportion of subepithelial cells that were TLR4-immunoreactive was significantly 
higher in periodontitis tissue than in healthy gingiva (68.4 ± 13.7% in 38 periodontal pockets 
vs. 12.3 ± 5.6% in 10 control samples; P < 0.001, t-test). 
 
Transcript expression of TLR4, MD-2, CD14 and LBP in human gingival keratinocytes, 
fibroblasts and tissues 
The human TLR4 gene contains two alternative splicing exons (Fig. 4a), each of which may 
be present or absent in the final mature transcript, theoretically resulting in four mRNA 
splicing variants (Fig. 4b). We identified the splicing variants by RT-PCR using pairs of 
primers designed to amplify the splicing regions containing the exons. Using this method, 
three splicing variants, TLR4.1 (amplicon size: 518bp), TLR4.3 (amplicon size: 638bp) and 
TLR4.4 (amplicon size: 351bp) were identified in HGK, HGF and HGT (Fig. 4c). However, 
TLR4.2 splicing variant (amplicon size: 474bp) was not found despite repeated experiments. 
Similarly, MD-2 gene has one alternative splicing exon giving rise to two MD-2 splicing 
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variants. Both MD-2.1 (amplicon size: 422bp) and MD-2.2 (amplicon size: 333bp) were 
detected in HGK, HGF and HGT, but MD-2.1 appeared to be more prominent (Fig. 4d). 
Identity of the PCR products of these TLR4 and MD-2 splicing variants were further confirmed 
by gel-purification and subsequent DNA-sequencing (data not shown). 
CD14 mRNA was detected in HGK, HGF and HGT (Fig. 4e). LBP mRNA could only be 
detected in HGT but not in HGK or HGF (Fig. 4f). 
 
Protein expression of TLR4, CD14 and MD-2 in human gingival tissue and cells and 
their association in HGF and HGK 
The TLR4 protein was detected by immunoprecipitation and immunoblotting from the 
lysate of HGF, HGK, HGT and periodontitis gingival tissue (PGT) and was found to have a 
molecular mass of about 120 kDa (Fig. 5c). The CD14 and MD-2 proteins were detected in 
HGF, HGK, HGT and PGT by immunoblotting showing molecular mass of 55 kDa and 20 
kDa, respectively (Fig. 5a & 5b). The authors did not attempt to quantity CD14, MD-2 and 
TLR4 peptide expression from HGF or HGK cultures. However, the research group did not 
observe varied detectability of CD14, MD-2 and TLR4 from HGF of the ten control 
specimens, or the three HGT/PGT tissue biopsies. 
In human gingival fibroblasts and keratinocytes, both CD14 and MD-2 could be 
individually co-immunoprecipitated with TLR4 protein (Fig. 5B), suggesting associations of 
TLR4/CD14 and TLR4/MD-2. However, CD14 and MD-2 did not co-immunoprecipitate, 
indicating that these two HGF and HGK molecules did not form a direct or indirect complex 
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with each other in vitro (data not shown). 
 
 
Discussion 
The innate extracellular signaling pathway of LPS pattern recognition mainly involves the 
interaction of co-receptor CD14, accessory molecules LBP, MD-2 and corresponding PAMP 
receptor TLR4. Many studies attempted to investigate the expression of these proteins in 
human gingival cells and tissues—the results have been to some extent confusing. For 
example, although the in vitro expression of TLR4 in gingival keratinocytes and fibroblasts 
has been reported (3-6), previous immunohistochemical studies yielded inconsistent results 
regarding the in vivo gingival distribution of TLR4 (3, 7-10). While in some studies (8, 10) 
TLR4 was reported in immune cells of gingival connective tissues, others (3, 7, 9) presented 
with evidence that TLR4 could be identified in human gingival epithelium and enhanced in 
periodontitis. None of these studies described any distinctive TLR4 expression profiles on 
junctional epithelium, oral sulcular epithelium and oral epithelium, which play distinctive roles 
in the pathogenesis of periodontitis. In the present study, we defined in details the expression 
profiles of TLR4 in healthy and periodontitis-involved human gingiva and in junctional, oral 
sulcular, oral and pocket epithelium, followed by examination of the transcript and protein 
products of TLR4, CD14 and MD-2 in primary gingival cell cultures from healthy subjects, 
and periodontal soft tissues biopsies from health and disease.  
Some previous studies reported that periodontitis associates with increased expression of 
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TLR4 in leukocytes (8) and epithelial cells (5) in human gingiva. However, in the present study, 
although apparently we confirmed that a higher proportion of leukocyte-like cells were stained 
positive for TLR4 in periodontitis than in healthy control (Fig. 1 & 2), the difference in 
epithelial expression of TLR4 between corresponding healthy or periodontitis compartments 
does not appear statistically significant (Fig. 3). The lack of difference between H-JE and P-PE, 
despite the latter appeared to express higher relative TLR4 level is probably a result of the 
limited sample size of this study. Nevertheless, for the first time, we described 
comprehensively the differential expressions of TLR4 protein in the periodontal epithelial 
barrier. Intriguingly, TLR4 expression appeared to be lower in junctional epithelium, 
compared to oral epithelium and oral sulcular epithelium (Fig. 3). It should be noted that we did 
not try to confirm these results in the subsequent in vitro experiments because currently these 
are no reliable methods to induce the cultured gingival epithelial cells to differentiate 
specifically toward junctional, oral sulcular or oral epithelial morphotypes. Nevertheless, how 
this distinctive expression profile of TLR4 in human gingival epithelium impacts on 
periodontal pathogenesis warrants further studies. We believe these results suggest the 
possibility that at least in healthy gingiva different epithelial compartments may be 
programmed to sense LPS challenge differently.  
Possibly due to the lower expression level of TLR4 peptide in gingiva, the effort of 
identifying cell types in periodontal tissues using double immunofluorescence methods failed 
(data not shown). As a consequence, cell-type identification is mainly based on cell 
morphology and location in the tissue section where certain cells were observed. The 
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expression of TLR4 in some leukocyte subpopulations was preliminarily demonstrated in 
periodontitis tissues (Fig. 2c & 2d). The epithelium-infiltrating cells in both healthy and 
periodontitis tissues (possibly neutrophils and γδ-T cells according to the cell localization) 
showed little staining for TLR4 (Fig. 1c, 1d, 2c & 2i). Specifically, the immune cells present in 
the healthy gingiva were mostly negative for TLR4 (Fig. 1c & 1d). Further studies to profile 
the transcript/peptide expression of TLR4, CD14 and MD-2 in HGT in vivo, in particular 
those from residential and defense cells may help shed light on the biological relevance of all 
cells capable of PAMP recognition in human periodontium. 
Human TLR4 gene contains two alternative exons (exon a and b) that can be present or 
absent in the final mature mRNA (Fig. 4a), theoretically forming four splicing variants. These 
variants are products of two splicing exons inserted together, inserted individually or absent in 
the open reading frame (ORF) of TLR4 at 93 bp downstream of the translation starting site (Fig. 
4b). Exon b is required to maintain the integrity of ORF, but loss of exon b or presence of exon 
a results in frame-shifting or premature in-frame stop codon, respectively. Only TLR4.1 that 
contains exon b can be translated into the full-length functional protein. Initially, all the four 
TLR4 splicing variants were reported observable from human monocytes (11). But now it is 
believed that existence of variant TLR4.2 (GenBank accession number: NM_138556) is 
insufficiently supported. As a result, NM_138556 has been permanently removed from 
GenBank database (16).  
Using RT-PCR, we identified the expression of TLR4.1, TLR4.3 and TLR4.4 transcript 
variants in healthy human gingival tissues and cultured gingival keratinocytes and fibroblasts. 
Page 19 of 37
Journal of Periodontal Research
Journal of Periodontal Research - manuscript proof
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Manuscript proof
 
20 
 
Currently, there is no data regarding the precise biological significances of these splicing 
variants expression in human. However, a similar alternatively spliced mouse TLR4 mRNA 
was reported to produce a truncated protein, which competitively inhibits TLR4 signaling (17). 
Our findings show these three variants are present in gingival cells and tissues at comparable 
levels (Fig. 4c). Therefore, when evaluating the transcriptional level of the TLR4 gene, the 
non-protein coding transcripts of TLR4.3 and TLR4.4 should be detected and quantified to take 
into account and avoid any possible bias or misinterpretation. 
For the first time, we have identified the TLR4 glycoprotein in both human gingival 
keratinocytes and fibroblasts using immunoprecipitation and immunoblotting. All 
immune-detected human glycopeptides molecular sizes were in agreement with reports in the 
literature (please see below). Furthermore, the in vitro expressions of signals for the above 
glycoproteins were characterized using the same HGF explant. The later substantiated in part 
the validity of our glycoprotein interaction experiments. We also considered periodontitis 
tissue could function as positive control because of its heavy inflammatory cells infiltration 
meaning proteins like CD14, MD-2 and TLR4 expressed by macrophages, monocytes and 
other leukocytes could be readily isolated or detected (8, 10). Negative control for HGF 
explant study carried out by replacing protein samples with BSA in protein extraction buffer.  
Probably dependent on the amount of glycosylation, the molecular mass of the TLR4 
could be 96 or 120 kDa. Glycosylation is reported to be closely involved with the biological 
function of the TLR4 receptor complex by affecting its cell surface localization, protein 
complex formation, and LPS responsiveness (18). In this study, human gingival tissue as well 
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as cultured keratinocytes and fibroblasts were found to express the 120 kDa TLR4 protein, 
which has been reported to be the most biologically active form among the different 
glycosylated variants (18). 
Furthermore, the TLR4 protein in gingival fibroblasts and keratinocytes 
co-immunoprecipitated with MD-2 or CD14 from the same cellular source (Fig. 5e-g), 
confirming the in vitro presence of TLR4/CD14 and TLR4/MD-2 complexes, as hypothesized 
in previous reports (19-21). However, CD14 and MD-2 did not co-immunoprecipitate and did 
not form complexes in vitro (data not shown) suggesting that these two HGF or HGK 
originating molecules are not directly associated with each other (1). 
Two MD-2 splicing variants were identified in gingival cells and tissue (Fig. 4d). The 
shorter MD-2.2 variant lacks the splicing exon compared to the longer MD-2.1 variant (12). It 
is believed that MD-2.2 negatively regulates TLR4-signaling by competitively inhibiting the 
binding of MD-2.1 protein to TLR4 (22). However, in this study only a single band of MD-2.1 
protein of around 20 kDa was detected (Fig. 5b). Possibly the mRNA levels of MD-2.2 were 
much lower than that of MD-2.1 (Fig. 4d) resulting in an undetectable MD-2.2 protein 
expression level. It has been reported that inflammatory cytokines such as IFN-γ and IL-6 
induce MD-2.2 in vitro (22). This suggests that tissue inflammation may increase MD-2.2 
expression that would negatively regulate LPS/TLR4 signaling. Further studies are needed to 
clarify this hypothesis. 
We could not detect LBP mRNA in both primary gingival keratinocytes and fibroblasts 
cultured from healthy gingival tissues (Fig. 5). Also, E. coli LPS and/or hypoxia treatment used 
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as simulators to mimic periodontal infection did not induce LBP transcripts in these cells (data 
not shown). The present results are in contrast to a previous immunohistochemistry study from 
our research group that LBP appeared to be expressed in the cytoplasm of gingival epithelial 
cells (23). However, LBP mRNA was detectable in healthy gingival tissue (Fig. 4f). It is likely 
that LBP peptide found in gingival tissue was principally produced in liver and then locally 
delivered via blood vessels, while the remaining LBP might be locally produced by gingival 
tissue cell types other than keratinocytes or fibroblasts. 
It should be noted that primary cells used in this study were all cultured from healthy 
gingival tissues; theoretically, their behaviors might be different compared to those from 
periodontitis tissue. Observation from current report that in vivo TLR4 expression on 
junctional/pocket epithelia in periodontal health and disease (Fig. 3) remain not significant 
different despite TLR4 expression in pocket epithelium under inflammatory conditions tended 
to be higher. Further experiments with bigger sample size are needed to confirm such 
postulation.  
    
Conclusions 
This study provides strong evidence for the expression of TLR4, CD14 and MD-2 in both 
human gingival keratinocytes and fibroblasts. For the first time, we reported the expression 
levels of TLR4 protein in different periodontal epithelial compartments in vivo, in particular 
the lower expression level of the PAMP of interest in junctional epithelium indicating the 
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possibility of heterogeneous nature of LPS-sensing in the dentogingival front in health. 
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Legends 
 
Fig. 1. TLR4 protein expression profiles in healthy gingiva (DAB stain. Scale bars represent 
200 µm, 50 µm or 25 µm as indicated). a) micrograph of healthy gingiva. b) to e) show 
magnified regions. TLR4-immunoreactivity could be found in oral epithelium (OE; b) and 
oral sulcular epithelium (OSE; b, c & e), but occasional in junctional epithelium (JE; d). 
Fibroblast-like cells (open arrows; c, d) show slight TLR4-immunoreactivity. Leukocyte-like 
cells (open and solid arrow heads) were scattered in OSE, JE and subepithelial regions of 
healthy gingiva (c, d). Most leukocyte-like cells including those epithelium-infiltrating were 
not TLR4-immunoreactive (open arrow heads), except those with dendritic morphology were 
TLR4 positive (solid arrow heads). The TLR4-positive staining in endothelial cells (arrows) 
was very weak or absent. 
 
Fig. 2. TLR4 protein expression profiles in shallow (A) or deep (B) periodontal pockets 
(DAB stain. Scale bars represent 200 µm, 50 µm or 25 µm as indicated). a) is a section of 
shallow periodontal pocket biopsy. b) to d) show magnified regions. e) is a section of deep 
periodontal pocket biopsy f) to j) show magnified regions. TLR4-immunoreactivity could be 
found in oral epithelium (OE; d) and pocket epithelium (PE; c, g). Compared to healthy 
gingiva (Fig. 1c, 1d) where fibroblasts were mostly free of TLR4-immunoreactivity, 
fibroblast-like cells in periodontitis tissue (f, i; open arrows) proximal to inflammatory front 
were heavily stained. Leukocyte-like cells (open and solid arrow head) appeared densely 
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infiltrated the periodontitis tissue (f, j). Although most epithelium-infiltrating leukocyte-like 
cells were not TLR4-immunoreactive (open arrow head), those in the subepithelial region 
were more intensively stained (solid arrow head) than in healthy gingiva (Fig. 1d). 
TLR4-positive inflammatory cells appeared to accumulate around the front of the 
periodontitis lesion (h, k), which are characterized by a mass of densely infiltrating 
leukocytes. The proportion of subepithelial cells that were TLR4-positive was significantly 
greater in periodontitis tissue than that in healthy controls (compared to Fig. 1: 68.4 ± 13.7% 
in 38 periodontal pockets vs. 12.3 ± 5.6% in 10 control samples; P < 0.001, t-test. ). 
 
Fig. 3. Area TLR4 positive (mean ± SD percentage proportion) at various epithelial 
compartments observable in histological sections of periodontal biopsies. Significant higher 
proportions of area positively stained for TLR4 [area TLR4 positive (%)] were observable at 
healthy oral epithelium (H–OE, n=10), oral sulcular epithelium (H-OSE, n=10) and 
periodontitis oral epithelium (P-OE, n=38), compared to junctional epithelium (H-JE, n=10; 
one-way ANOVA with Bonferroni multiple comparisons, **P=0.01, ***P=0.001). Area TLR4 
positive (%) in pocket epithelium (P-PE, n=38) was not statistically different to that of other 
diseased or healthy epithelial compartments. 
 
Fig. 4. The mRNA expression of TLR4, MD-2, CD14 and LBP in primary human gingival 
keratinocytes (HGK), fibroblasts (HGF) and healthy gingival tissue (HGT). a) Human TLR4 
gene includes two exons a and b, which results in four possible splicing variants. b) Possible 
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splicing variants TLR4.1, TLR4.2, TLR4.3 and TLR4.4. A pair of PCR primers (P1 and P2) 
was designed to amplify the splicing variants containing exons a and b. c) Three TLR4 
splicing variants, TLR4.3, TLR4.1 and TLR4.4 were found in HGF, HGK and HGT. d) Two 
mRNA splicing variants of MD-2, MD-2.1 (containing the splicing exon) and MD-2.2 
(lacking the splicing exon) were found in HGF, HGK and HGT. MD-2.1 appears to be 
expressed more in gingival cells and tissue. e) CD14 mRNA was detected in HGF, HGK and 
HGT. f) LBP mRNA was found in HGT, but not in HGK or HGF. 
 
Fig. 5. Protein expression of CD14, MD-2 and TLR4 in human gingival tissue and cells (A) 
and association between CD14, MD-2 and TLR4 peptides expressed in HGF and HGK (B). 
Proteins were immunoprecipitated (IP) and immunoblotted (IB) from the whole cell or tissue 
lysate (500 µg cellular protein or 800µg tissue protein for TLR4 and CD14, 20 µg protein for 
MD-2). The anti-human antibody species were Rb: rabbit, Ms: mouse and Gt: goat. BSA: 
bovine serum albumin (500 µg) negative control lane. A. Protein expression of a) CD14, b) 
MD-2 and c) TLR4 in human peripheral blood mononuclear cells (PBMC, positive control), 
human gingival fibroblasts (HGF), human gingival keratinocytes (HGK), healthy gingival 
tissue (HGT) and periodontitis gingival tissue (PGT). B. The association between CD14, 
MD-2 and TLR4 proteins expressed in HGF and HGK. Whole HGF, HGK and PBMC 
(positive control) lysate (500 µg protein each) and BSA (500 µg, negative control) were IP 
with anti-CD14 (e), -MD-2 (g) or -TLR4 (d, f) antibody, and IB with the relevant anti-human 
antibody. d) and e) TLR4 and CD14 peptides were co-immunoprecipitated. f) and g) MD-2 
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and TLR4 peptides were co-immunoprecipitated. CD14 and MD-2 did not 
co-immunoprecipitate (data not shown), indicating the two molecules are not directly 
interacting with each other. 
 
Supplementary Fig. S1. Semi-quantification of positive immunohistochemical (IHC) staining. 
Panel A. Field selections in anti-TLR4 antibodies stained healthy gingival tissue: a 
(corresponding to Fig. 1b), b (corresponding to Fig. 1d) or periodontitis tissue: c 
(corresponding to Fig. 2b), d (corresponding to Fig. 2g). Non-overlapping fields of interest 
(FOI) [oral epithelium (OE)/oral sulcular epithelium (OSE): 5,000-30,000 µm
2
, junctional 
epithelium (JE)/pocket epithelium (PE): 5,000-15,000 µm
2
, or deep PE: 5,000-75,000 µm
2
 
rectangular boxes) were defined in antibodies stained image sections: JE (g), OE (f, i), OSE 
(e) and PE (h, j). The TLR4 IHC staining quantification was as described in Panel B. k: 
Defining a FOI via drawing a rectangle in a digital image acquired from a stained section 
(shown is an OSE section); l: Assigning a surrogate color (in this case blue color was selected) 
for DAB stain (brown) indicating positive immunolabeling; m: Using Leica Qwin Standard V 
2.6 software (Leica, Wetzlar, Germany) to measure the area percentage (Area%). 
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